Overview - The prevalence of respiratory diseases in China has been increasing due to factors such as air pollution, aging population, and unhealthy lifestyles, particularly among the elderly [1][6] - The clinical adoption rate of lung function tests has been low, but rising health awareness among residents is driving demand for clinical diagnostics and home monitoring [1][6] - In 2024, the total procurement amount for lung function devices in China is projected to be 422 million yuan, remaining stable compared to 2023, but the total procurement volume is expected to decline significantly to 1,602 units due to rising average procurement prices [1][6] Market Policies - The medical device industry, including lung function devices, is a strategic emerging industry in China, receiving significant attention from the government through various policies aimed at promoting development and ensuring product quality [4][6] Industry Chain - The upstream of the lung function device industry includes suppliers of raw materials and core components, while the midstream involves R&D, design, and production, and the downstream encompasses demand markets such as hospitals and home care [3][4][6] Current Development - The demand for lung function devices is expanding due to the increasing number of medical institutions and the rising prevalence of chronic respiratory diseases, with significant growth in the home care segment [6][8] - By the end of 2024, the number of medical institutions in China is expected to reach 1.092 million, with hospitals and grassroots medical institutions showing notable growth [6] Competitive Landscape - Foreign brands like Jaeger, Cosmed, and KORR dominate the high-end market, holding a 64.84% market share in imported lung function devices, with Jaeger leading at 35.50% [8][9] - Domestic brands such as RuiChao and Huxi are gradually improving their technology and market presence, with RuiChao holding a 9.63% market share [8][9] Future Development Trends - The future of lung function devices will focus on smart technology integration, including AI-assisted diagnostic systems and enhanced portability for home use [11][12] - There will be a rise in specialized devices tailored for specific demographics and conditions, such as pediatric devices and those designed for high-altitude environments [11][12]

Core Insights - The portable spirometer market in China is projected to reach 444 million yuan in 2024, reflecting a year-on-year increase of 9% driven by policy support and rising demand [1][7]. Industry Overview - Portable spirometers are essential medical devices for lung function testing, first introduced by Breath Home in 2014, and have received certifications from NMPA, FDA, and CE [3]. - These devices are compact, easy to carry, and suitable for various settings, including community health service centers and home monitoring, facilitating early detection of chronic respiratory diseases [3][4]. Market Dynamics - The aging population in China is increasing, with the elderly population expected to reach 219.69 million by the end of 2024, contributing to a higher prevalence of chronic respiratory diseases and a growing demand for lung function tests [4]. - The number of medical institutions in China is projected to reach 1,093,600 by 2024, a year-on-year increase of 2.13%, indicating a growing market for portable spirometers [5]. Competitive Landscape - The market has historically been dominated by international brands like Jaeger and R spirometry, but domestic companies such as Mindray, Yuyue Medical, and Kangtai Medical are gaining market share through innovation and expansion [9]. - Mindray reported a revenue of 25.834 billion yuan in the first three quarters of 2025, a decrease of 12.38% year-on-year, while Kangtai Medical achieved a revenue of 344 million yuan in the first half of 2025, an increase of 3.03% year-on-year [10][11]. Development Trends - The industry is expected to see continuous technological innovation and product upgrades, with the integration of IoT, big data, and AI enhancing the precision and intelligence of portable spirometers [11]. - Competition is intensifying as both domestic and international brands increase R&D investments and market efforts, leading to potential mergers and acquisitions within the industry [12]. - The pace of domestic substitution is accelerating, with local manufacturers poised to replace imported products as they enhance their technological capabilities and market presence [13].